Viral Excretion Among COVID-19 Omicron Recurrence Patients

• Conditions: Surface Contamination; COVID-19 Recurrence

• Registration Number: NCT05470426
• Lead Sponsor: RenJi Hospital

Brief Summary

The study analyzes the viral nucleic acid excretion and its influencing factors of SARS-COV-2 Omicron recurrence patients.

Detailed Description

Not available

Study Timeline

• Status Verified: 2022-07
• Study Start: 2022-07
• Study First Submitted: 2022-07-20
• Study First Submitted QC: 2022-07-20
• Last Update Submitted: 2022-07-20
• Study First Posted: 2022-07-22
• Last Update Posted: 2022-07-22
• Primary Completion: 2023-07
• Study Completion: 2023-08

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

• Patients with nucleic acid detection N gene and ORF gene Ct value < 40 after discharge from hospital
• Being able to provide basic information, living habits, vaccination information, admission information

Exclusion Criteria

• Single gene target positive
• Patients with incomplete baseline data

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
COVID-19 Omicron Recurrence	Six months	COVID-19 Omicron Recurrence

Trial Locations

Locations (1)

Renji Hospital; 🇨🇳 Shanghai, China